Search results
Apr 29, 2024 · The term describes a usually faint and mild cutaneous eruption that exhibits the combined characteristics of macules (discolored areas of skin that are not elevated above the surface) and papules (small, solid, usually inflammatory elevations of the skin that do not contain pus), and the rash is often referred to as morbilliform (in resembling ...
May 5, 2024 · Exanthems (erythematous, morbilliform or maculopapular), urticaria, fixed drug eruptions, and erythema multiforme are the most common. Figure 18-1 is an urticarial reaction from Augmentin and Fig. 18-2 shows a morbilliform eruption from ampicillin.
May 2, 2024 · Maculopapular, or morbilliform, eruptions are typically slower to come on and do not morph quickly. Lesions last more than 24 hours and fade without scarring. There may be a fine skin peeling as this rash resolves. Other rashes that that are severe include those that scar the skin or involve a fuller thickness skin peeling.
Apr 28, 2024 · Less commonly, rashes are described as papules (14%), macules (12%), or morbilliform (9%). The extent of detached skin typically involves less than 10% of the body surface area. In contrast, erythema multiforme presents initially as a cutaneous acral rash with macules that evolve into papules, plaques, and typical target lesions.
Apr 24, 2024 · Six days later she broke out with a red rash all over her body (Figure 203-1). She went to see her family physician back home with the rash and lymphadenopathy. A monospot was drawn and found to be positive. This morbilliform rash (like measles) is typical of an amoxicillin drug eruption in a person with mononucleosis.
6 days ago · The rash, which is created by the dissemination of the virus and the immune system’s response to it, is often described as morbilliform, which is a measles-like eruption. It usually looks red, with both flat and raised patches of skin that are covered with small, raised bumps.
Apr 20, 2024 · Though gastrointestinal symptoms are the most common side effect, up to 15% of patients on MTX have been shown to develop a nonspecific morbilliform rash, and in severe cases bullae formation and toxic epidermal necrolysis.
